Atlas Trials

A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia

Clinical trial NCT00117039 · COMPLETED

Trial details

NCT number
NCT00117039
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
AnemiaNeoplasms
Start date
2004-01-01
Enrollment
1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.